Fumiaki Ando Selected Research

Sodium Chloride Symporters

1/2020	Renal TNFα activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease.
1/2019	Tacrolimus ameliorates the phenotypes of type 4 Bartter syndrome model mice through activation of sodium-potassium-2 chloride cotransporter and sodium-chloride cotransporter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fumiaki Ando Research Topics

Disease

4	Nephrogenic Diabetes Insipidus 10/2021 - 11/2016
4	Pseudohypoaldosteronism 01/2017 - 09/2015
3	Polyuria 10/2021 - 06/2018
3	Chronic Renal Insufficiency 05/2021 - 01/2019
2	Fibrosis (Cirrhosis) 05/2021 - 01/2019
2	Bartter Syndrome (Syndrome, Bartter) 01/2021 - 01/2019
2	Hyperkalemia 01/2020 - 01/2019
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020 - 01/2019
1	Inflammation (Inflammations) 05/2021
1	Sepsis (Septicemia) 12/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2020
1	Alkalosis 01/2019
1	Hypokalemia 01/2019
1	Diabetes Mellitus 01/2018
1	Sarcopenia 01/2017
1	Hypertrophy 01/2017
1	Heart Failure 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Thyroiditis 11/2013
1	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2013
1	Pulmonary Sarcoidosis 11/2013
1	Sarcoidosis (Schaumann Disease) 11/2013
1	Glomerulonephritis 06/2013
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 06/2013
1	Long QT Syndrome 05/2011
1	Torsades de Pointes (Torsade de Pointes) 05/2011

Drug/Important Bio-Agent (IBA)

5	Vasopressins (Vasopressin)IBA 10/2021 - 11/2016
5	Lysine (L-Lysine)FDA Link 01/2020 - 09/2015
5	Phosphotransferases (Kinase)IBA 01/2020 - 09/2015
4	SodiumIBA 01/2020 - 11/2015
2	Aquaporins (Water Channels)IBA 10/2021 - 06/2018
2	PotassiumIBA 01/2020 - 01/2019
2	SaltsIBA 01/2020 - 01/2019
2	Tolvaptan FDA Link 01/2020 - 01/2019
2	Sodium Chloride SymportersIBA 01/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 05/2011
2	Member 3 Solute Carrier Family 12IBA 01/2019 - 11/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2021
1	Aquaporin 2IBA 10/2021
1	Prostaglandin D2IBA 05/2021
1	Collagen Type I (Type I Collagen)IBA 05/2021
1	LipidsIBA 05/2021
1	EnzymesIBA 05/2021
1	DiureticsIBA 01/2021
1	CytokinesIBA 12/2020
1	sodium-calcium exchanger 1IBA 01/2020
1	Alanine (L-Alanine)FDA Link 01/2020
1	SEA 0400IBA 01/2020
1	Proline (L-Proline)FDA Link 01/2020
1	4- hydroxy- 3- (4- (2- hydroxyphenyl)phenyl)- 6- oxo- 7H- thieno(2,3- b)pyridine- 5- carbonitrileIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	ChloridesIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Member 1 Solute Carrier Family 12IBA 01/2019
1	Calcineurin InhibitorsIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2015
1	AntibodiesIBA 11/2013
1	anti-thyroglobulinIBA 11/2013
1	SteroidsIBA 11/2013
1	Prednisolone (Predate)FDA LinkGeneric 11/2013
1	erythrogenic toxinIBA 06/2013

Therapy/Procedure

1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2019